Swiss Re identifies underwriting and risk factors for repurposed anti-aging drugs
Swiss Re has highlighted significant issues for advisers where drugs originally developed to treat other conditions are being used by ...
Read more
Tag: longevity drugs
HAVE YOU READ?
MOST POPULAR
-
The UK Health & Protection Awards 2025 supplement – the winners
-
Aviva extends EAP to all group protection customers
-
PMI-funded hospital admissions down in Q2 2025 – PHIN
-
Preventative health services have real benefits but need further work – analysis
-
Vote for the PMI and protection providers giving you the best service
